Vitadral

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitadral

Quick Facts Description
Active Ingredient Vitamin A (Retinol)
Form Oral Solutions or Soft-Gel Capsules
Pharmacological Class Fat-Soluble Vitamin / Micronutrient
Common Use Prevention and correction of Vitamin A Deficiency
Origin Essential, prepared as Natural or Synthetic Retinoids

What Type of Medicine is Vitadral?

Vitadral is a therapeutic supplement or preparation whose primary component is Vitamin A, scientifically identified as Retinol and its biologically active derivatives. It is classified as a Fat-Soluble Vitamin and is an Essential Micronutrient Replacement. This classification means the body cannot sufficiently produce Retinol on its own, making external intake necessary for health.

The core purpose of Vitadral is to prevent or correct the condition known as Hypovitaminosis A, ensuring the body's reserves of this essential compound are consistently maintained. In populations at risk of deficiency, supplementation plays a role in sustaining essential health metrics and supporting the correction of nutritional gaps.


Composition, Form, and General Purpose

The composition of Vitadral features Vitamin A in bioavailable forms, such as Retinyl Palmitate or Retinyl Acetate. These active compounds are commonly dissolved in an Oily Base due to their fat-soluble nature. For systemic use, the product is predominantly prepared as oral solutions (drops) or soft-gel capsules, facilitating oral administration. Vitadral is often specifically positioned for pediatric and adolescent patient groups, emphasizing its suitability for liquid dosing.

The use of an Oily Base supports the substance's stability and maximizes its absorption into the bloodstream via the body’s natural lipid pathways. This preparation is a Single-ingredient product designed to sustain multiple physiological actions. Vitamin A is critical for regulating the health of the Epithelial Cells lining the body's internal and external surfaces. Maintaining adequate levels of this vitamin supports tissue integrity throughout the body.


Fundamental Role of Vitamin A (Retinol)

Retinol plays a foundational role in maintaining healthy tissue integrity and functional systems, most notably in vision and immunity. It is crucial for the process of Vision Phototransduction and helps regulate the proper maintenance of the body's protective layers, including the skin and mucous membranes. This vital regulatory role in tissue maintenance and Immune Function ensures support for normal growth and development.

Regulatory References

  1. WHO: Vitamin A deficiency

What side effects are possible with Vitadral?

Possible Side Effects and Safety Information

Adverse effects associated with Vitadral (oral Vitamin A/Retinol) primarily relate to Hypervitaminosis A, which is the state of toxicity resulting from the accumulation of the fat-soluble vitamin in the body due to excessive intake. Regulatory documents classify potential adverse reactions based on the duration of exposure: Acute Toxicity (following a massive, single dose) and Chronic Toxicity (from long-term, consistently high intake).


System-Organ Classes and Exposure Patterns

The officially documented adverse reactions span multiple physiological systems. Symptoms associated with chronic toxicity often involve Skin and Subcutaneous Tissue Disorders, manifesting as dry skin, hair loss (alopecia), and itching (pruritus). Nervous System Disorders like headache and dizziness, and Musculoskeletal Disorders such as bone and joint pain, are also reported in cases of accumulation.


Serious Adverse Reactions

The regulatory profile highlights several serious adverse reactions linked to significant or prolonged excess. These include Increased Intracranial Pressure (Pseudotumor Cerebri), which can cause severe headaches, and the potential for severe Hepatic Damage, including cirrhosis. For individuals of child-bearing potential, high daily intake is an established safety concern due to the risk of Teratogenicity (severe birth defects).


Population-Specific Safety Notes

Specific safety considerations are noted in official labeling for vulnerable groups. Infants and children are more sensitive to the effects of toxicity, with signs such as a bulging fontanelle documented in infants. For older adults or postmenopausal women, prolonged high intake is linked to a potential increase in the risk of bone fracture. Additionally, co-administration with certain medications, such as tetracycline antibiotics, is officially noted to elevate the risk of intracranial hypertension.

Overdose and Emergency Response

Vitadral overdose, known as Hypervitaminosis A, is detailed in official regulatory sources across two categories: Acute (single massive ingestion) and Chronic (prolonged excessive intake). Acute toxicity manifestations include vomiting, drowsiness, and later, widespread skin peeling. Chronic toxicity signs involve bone and joint pain (arthralgia), alopecia (hair loss), and potential hepatomegaly (enlarged liver).

The regulatory profile highlights that overdose can lead to severe neurological consequences, including Increased Intracranial Pressure (IIH), which is a potentially life-threatening event. Due to this risk, immediate medical attention or contacting emergency services is mandated for symptoms such as a severe, persistent headache or visual disturbances.

The required primary action is the immediate discontinuation of the Vitamin A supplement. Management is strictly symptomatic and supportive, as official labels state that no specific antidote is known. Regulatory documents also specify that pregnant women are a high-risk group due to the potential for teratogenicity (birth defects), and infants may show unique signs like a bulging fontanelle.

Therapeutic Uses of Vitadral

What Vitadral Treats: Main Uses and Benefits

Vitadral is a therapeutic preparation whose core purpose is to help address Hypovitaminosis A (Vitamin A deficiency). Its uses are focused on supporting physiological functions compromised by this lack of essential micronutrient, providing support across three primary domains. Vitamin A is considered relevant for immune function, cellular communication, and vision.

Vitadral is commonly used to help with conditions marked by systemic depletion and is applied to address symptom clusters that may include impaired dark adaptation, Nyctalopia (night blindness), and Xerophthalmia (pathological eye dryness). It is also relevant when increased susceptibility to infection is present due to deficiency. The primary therapeutic indications are the prevention and correction of Hypovitaminosis A itself, the management of ocular surface disorders, and the provision of nutritional support in vulnerable patient groups, such as pediatric patients requiring assistance with normal growth and development. This replacement therapy is considered relevant for individuals with malabsorption syndromes or those in nutritionally vulnerable populations. It provides support that helps ease the overall symptom burden and assists with maintaining functional stability.

Quick Fact: Relief for Impaired Sensory Function
Vitadral is used for managing symptoms related to systemic imbalance, particularly those that affect vision and immune response, supports patients during episodes of heightened discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Vitadral?

The eligibility for using Vitadral (Vitamin A/Retinol) is strictly governed by official regulatory criteria, primarily focusing on avoiding the condition of toxicity known as Hypervitaminosis A.


Absolute Contraindications

Vitadral must not be used by patients who meet any of the following criteria, as stated in regulatory labels:

  • Hypervitaminosis A: Individuals who already have excessively high levels of Vitamin A in their bodies.
  • Hypersensitivity: Patients with a known allergy to Vitamin A (retinol/retinoids) or any other component of the preparation.
  • Concurrent Retinoid Use: Patients taking other systemic retinoid medications (e.g., isotretinoin, acitretin) due to the significant risk of additive toxicity.

Restricted or Conditional Use

Use is highly restricted in specific populations due to the risk profile:

  • Pregnancy: High-dose use (typically exceeding 10,000 IU daily) is prohibited or contraindicated due to the officially documented risk of fetal malformations (teratogenicity). Lower doses are permitted only for deficiency correction under medical guidance.
  • Liver Disease: Use is restricted or requires caution in patients with severe hepatic impairment (liver disease) due to Vitamin A's storage in the liver and the risk of exacerbating toxicity.
  • Renal Failure: Caution is required for patients with chronic renal failure as kidney impairment may lead to elevated blood concentrations of the vitamin.

Age-Group Eligibility

Vitadral is officially established for use in pediatric patients (infants and children) for deficiency correction, though dosing is critical due to their increased susceptibility to toxicity. Use in adults and older adults for deficiency treatment is permitted, provided no contraindications are present.

What should I know about interactions with other medicines?

Vitadral Interactions with other medicines and products

This section outlines the officially documented interaction patterns of Vitadral (Vitamin A / Retinol) as noted in government regulatory labeling.

Interaction Scope

Category Details (Official Regulatory Information)
Medicinal product categories with documented interactions Systemic Retinoids, Oral Anticoagulants, Oral Contraceptives, Bile Acid Sequestrants, Hepatotoxic Agents.
Specific interacting medicines (if explicitly listed) Warfarin, Cholestyramine, Acitretin, Isotretinoin.
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic synergism, Absorption reduction, Systemic exposure increase, Increased anticoagulant effect.
Interaction-related restrictions Strict prohibition on co-administration with other Systemic Retinoids due to the risk of Hypervitaminosis A (additive toxicity).

Official Interaction Statements

  • Co-administration with Systemic Retinoids is formally contraindicated due to the risk of pharmacodynamic synergism leading to severe adverse effects.
  • Oral Contraceptives have been documented to increase serum Vitamin A levels, resulting in greater systemic exposure of the vitamin.
  • High-dose Vitadral co-administered with Warfarin may increase the effect of the anticoagulant, which raises the official risk of bleeding complications.
  • Bile Acid Sequestrants (e.g., Cholestyramine) and Mineral Oil reduce Vitamin A's intestinal absorption, potentially leading to reduced plasma levels.
  • Co-administration with products known to cause hepatotoxicity is restricted due to the potential for an additive risk of liver injury.
  • Interactions have an altered risk profile in patients with hepatic or kidney disease due to official documentation stating that these conditions can impair the normal clearance of Vitamin A.

Mechanism of Action

Vitadral acts via its active metabolite, retinoic acid, which functions as an agonist for specific Retinoid Receptors (RAR and RXR) found in the cell nucleus. This interaction causes the modulation (turning on or off) of gene transcription by binding to DNA response elements, which in turn regulates the differentiation of epithelial cells and influences mucosal barrier formation.

In a distinct pathway, a separate form, 11-cis-retinal, is required for forming rhodopsin, the light-sensitive pigment in the eye's photoreceptor cells. This function in the visual cycle is a rapid biochemical process that sustains the regeneration of rhodopsin, thereby facilitating phototransduction in low-light environments.

The retinoid signaling pathway is also key to cellular differentiation, guiding precursor cells to mature into their specialized roles, particularly within the immune system. By modulating the maturation and function of various immune cells, Vitadral influences the activity of the immune system.

Dosage and Administration Information

How to Use Vitadral: Official Administration Guidelines

Vitadral, an official Vitamin A preparation, is administered according to regimens that depend strictly on whether the goal is daily maintenance or acute deficiency correction. The standard, approved administration route is oral (solutions or capsules). The Intramuscular (IM) injection route is reserved as an alternative when oral absorption is compromised, such as in cases of severe malabsorption.

Dosing and Scheduling Patterns

Usage Goal Standard Regimen (Examples from Official Protocols)
Acute Deficiency Treatment Initial doses of up to 100,000 Units (IU) IM daily for three days, followed by a maintenance dose of 10,000 to 20,000 IU oral daily for up to two months.
Pediatric Prophylaxis A single high dose of 200,000 IU for children one year and older, administered orally in a cyclic pattern repeated every four to six months.

Oral administration is functionally required to occur with food due to the vitamin's fat-soluble nature, which supports systemic absorption. This principle dictates the practical timing of intake. For infants, special administration instructions exist where the oily liquid from a soft-gel capsule must be squeezed directly into the mouth to ensure proper dose delivery. The administration frequency is defined by the regimen: either continuous daily for maintenance, or intermittent/cyclic for prophylactic public health programs.

Recent Clinical Evidence

Vitadral (Vitamin A) was evaluated in major research, with the most extensive findings focusing on populations at risk of severe nutritional deficiency. The evidence base consists primarily of large-scale Randomized Controlled Trials (RCTs) and Meta-Analyses conducted by international health organizations.

Evidence for Use in Correcting Clinical Deficiency

Research primarily examined the patterns related to all-cause mortality and cause-specific mortality (such as those related to diarrhea and measles) in preschool-age children (6 months to 5 years) in deficient areas. Findings describe patterns related to monitored mortality outcomes in this specific group. Research also describes how symptoms changed concerning the incidence of infectious diseases like measles and diarrhea. Evidence remains highly concentrated in these populations, and results offer limited context for individuals who already maintain adequate vitamin levels.

Evidence for Deficiency-Related Eye Disorders

Regarding the management of deficiency-related eye disorders, research explored whether supplementation was associated with changes in specific clinical signs like Nyctalopia (night blindness) and the resolution of Xerophthalmia (eye dryness). The findings describe patterns where supplementation was associated with the resolution of these ocular symptoms in the observed deficient populations.

Evidence in Special Populations and Uncertainty

The evidence for patients with malabsorption syndromes (e.g., Inflammatory Bowel Disease) relies on Case Reports and small observational settings; these studies describe patterns where Vitamin A replacement was associated with the maintenance or raising of serum levels. What remains uncertain is the long-term durability of these responses, as follow-up durations were limited (typically 6 to 12 months). Data for certain groups remain insufficient, particularly for routine supplementation in adult populations, and the evidence quality varies across studies depending on the population and indication.

Frequently Asked Questions (FAQ)

Common questions about Vitadral (FAQ)

Q: Is Vitadral meant to be taken every day, or just as needed?

Official administration guidelines describe different patterns for taking Vitadral. For daily maintenance of the body's reserves, a continuous daily regimen is typically used. However, for acute deficiency correction or in public health programs, the medicine is often administered in an intermittent or cyclic pattern (e.g., a high dose repeated every few months).


Q: Can Vitadral be taken alongside common vitamin supplements?

Regulatory documents advise against co-administration with other Vitamin A products or retinoids because this combination significantly increases the risk of toxicity, known as Hypervitaminosis A. Official guidance emphasizes careful consideration of total Vitamin A intake from all sources, including supplements and fortified foods, to avoid exceeding safe upper limits.


Q: What does the patient-facing label say about 'overuse' of Vitadral?

The patient label directly addresses excessive intake by describing the risks of developing Hypervitaminosis A, or vitamin toxicity. This condition can result from taking too much medicine over a long period. Chronic symptoms reported in official documents include dry skin and headaches, with potential for severe effects like liver damage and increased pressure in the skull.


Q: Why is hydration sometimes mentioned when discussing Vitadral use?

Official product information notes that certain Skin and Subcutaneous Tissue Disorders, such as dry skin and itching, are possible side effects related to the medicine's accumulation in the body. Discussions about hydration relate to managing these documented symptoms that can affect the skin and mucous membranes.


Q: Why is patient compliance with Vitadral considered important?

Patient compliance is considered important because regulatory guidelines define very specific administration patterns, such as the need to take the medicine with food for proper absorption. Following the prescribed regimen (whether daily or cyclic) ensures that the medicine is used to meet its intended goal of deficiency correction or prophylaxis.


Q: How is the active ingredient in Vitadral absorbed by the body?

The active ingredient in Vitadral is a fat-soluble vitamin which means it is efficiently absorbed through the gastrointestinal tract. Official guidelines state that administration should occur with food because dietary fat is necessary to support this systemic absorption process.


Q: What is the main difference between Vitadral and other similar over-the-counter options?

The main difference, as defined by regulatory classification, often relates to the strength and intended use of the preparation. Therapeutic-level products like Vitadral are typically positioned for treating clinically confirmed deficiencies, whereas many over-the-counter supplements contain lower doses for general maintenance.


Q: Why do some users report feeling a change in appetite after starting Vitadral?

Regulatory documents note that a loss of appetite is listed among the possible symptoms. Appetite changes are noted in regulatory documents as a possible symptom associated with accumulation.


Q: Do older adults typically experience different side effects with Vitadral compared to younger people?

Official labeling includes specific safety considerations for older adults, which indicates a potentially altered risk profile. Specifically, prolonged high intake is documented as being associated with a potential increase in the risk of bone fracture in this demographic.


Q: Can Vitadral be used by people with certain mild allergies?

Vitadral is contraindicated (meaning use is officially prohibited) in patients who have a known hypersensitivity or allergy to the active ingredient (Vitamin A/retinoids) or any other non-active component of the specific preparation.


Q: Is Vitadral classified as an essential medicine by any global health organizations?

Yes, the active ingredient in Vitadral, which is Retinol (Vitamin A), is listed on the World Health Organization (WHO) Model List of Essential Medicines. This classification confirms its recognized importance for use in addressing deficiency conditions globally.


Q: Why might a patient need to stop taking Vitadral suddenly?

Discontinuation may be necessary if a patient develops signs of a serious adverse reaction, such as a severe headache or blurred vision, which could indicate increased intracranial pressure. Additionally, official guidelines mandate stopping if a formal contraindication (a condition that prohibits use) is identified, such as the concurrent use of other systemic retinoid medicines.


Q: Why is Vitadral typically taken at a certain time of day?

The official timing for oral administration is based on how the body absorbs the medicine. Because Vitadral is a fat-soluble vitamin, official guidelines indicate that it should be taken with food (which contains dietary fat) to support the proper uptake into the bloodstream.


Q: Is it safe to drive or operate machinery after taking Vitadral?

Official product information for some Vitadral formulations indicates that the medicine has no or negligible influence on a person's ability to drive or use machinery. However, regulatory documents do list dizziness and headache as possible side effects, and caution is warranted if these symptoms occur.


Q: What is the evidence theme regarding Vitadral's use in younger adult populations?

Research evidence for Vitadral is largely focused on patterns observed in treating deficiency in pediatric populations. Official summaries of the evidence indicate that data remains insufficient regarding the evidence theme for routine supplementation in generally healthy adult populations.


Q: Does taking Vitadral require any special monitoring by a healthcare professional?

Monitoring by a healthcare professional is typically required under specific conditions to ensure safety. This includes patients receiving prolonged high doses, or those with existing conditions like liver or kidney disease. Monitoring is also advised when the medicine is used alongside specific interacting medicines, such as Warfarin.


Q: Is there a generic version of Vitadral available in most regulated markets?

As Vitadral is a preparation of the essential micronutrient Vitamin A (Retinol), the active ingredient is broadly available in generic form. It can be found under various generic and brand names in regulated markets worldwide.

How should Vitadral be stored and disposed of?

How to Store and Dispose of Vitadral?

Storage of Vitadral, a Vitamin A preparation, must strictly follow regulatory guidance to maintain its integrity. The product requires storage at controlled room temperature, typically 20 C to 25 C.

It is mandatory to protect the medicine from light and moisture and avoid exposure to excessive heat or freezing temperatures. To prevent chemical degradation, the product must be kept in its original container and the cap should be tightly closed.

For safety, Vitadral must be kept out of the sight and reach of children.

Regarding disposal, regulatory documents advise patients to utilize a formal medicine take-back program for any unused or expired product. To protect the environment, the medicine must not be flushed down the toilet or poured into any drain (wastewater).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vitadral found in:

A-Z Index: